Quantification of Minimal Residual Disease Levels by Flow Cytometry at Time of Transplant Predicts Outcome After Myeloablative Allogeneic Transplantation in ALL

Bone Marrow Transplantation - United Kingdom
doi 10.1038/bmt.2012.147
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Relationship Between Minimal Residual Disease Measured by Multiparametric Flow Cytometry Prior to Allogeneic Hematopoietic Stem Cell Transplantation and Outcome in Children With Acute Lymphoblastic Leukemia

Haematologica
Hematology
2010English

Minimal Residual Disease Quantification by Flow Cytometry Provides Reliable Risk Stratification in T-Cell Acute Lymphoblastic Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2018English

Chimerism and Minimal Residual Disease Monitoring After Reduced Intensity Conditioning (RIC) Allogeneic Transplantation

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2002English

Pre-Transplant MRD Predicts Outcome Following Reduced-Intensity and Myeloablative Allogeneic Hemopoietic SCT in AML

Bone Marrow Transplantation
TransplantationHematology
2014English

Comparative Analysis of Minimal Residual Disease Detection Using Four-Color Flow Cytometry, Consensus IgH-PCR, and Quantitative IgH PCR in CLL After Allogeneic and Autologous Stem Cell Transplantation

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2004English

Two Colour Flow Cytometry Intensified by the Lysys II Program (Becton Dickinson) in the Detection of Minimal Residual Disease of All

Pediatric Research
Child HealthPediatricsPerinatology
1999English

Monitoring of Minimal Residual Disease in Multiple Myeloma After Allo-Sct: Flow Cytometry vs PCR-based Techniques

Bone Marrow Transplantation
TransplantationHematology
2008English

Detection of Minimal Residual Disease in Childhood B-Acute Lymphoblastic Leukemia by 4-Color Flow Cytometry

Journal of Hematology & Thromboembolic Diseases
2017English

Flow Cytometry in the Diagnosis and Monitoring of Minimal Residual Disease in Multiple Myeloma

Oncogematologiya
OncologyHematology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy